Recombinant human nerve growth factor(Sinobioway Biomedicine)
重组人神经生长因子（未名生物）
Report date: 2025/12/05 20:00:50
Base Information
Drug NameRecombinant human nerve growth factor(Sinobioway Biomedicine)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSinobioway Biomedicine Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesSinobioway Biomedicine Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A